Abstract
Background
The recurrence of thyroid cancer poses challenges compounded by postoperative fibrosis and anatomic changes. By overcoming the limitations of current localizing dye techniques, indocyanine green-macroaggregated albumin-hyaluronic acid (ICG-MAA-HA) mixture dye promises improved localization. This study aimed to evaluate the efficacy and safety of the dye for recurrent thyroid cancer.
Methods
The nine patients in this study underwent surgery and postoperative ultrasonography. The dye was injected into recurrent lesions in all the patients preoperatively. During surgery, the lesions were confirmed with an imaging system before and after excision. If the lesion was unidentifiable with the naked eye, surgical excision was performed under the corresponding fluorescent guide. Side effects related to the dye injection and completeness of the surgery were evaluated.
Results
No side effects such as bleeding, skin tattooing, or pain during or after the dye injection were reported, and no discoloration occurred that interfered with the surgical field of view during surgery. In three cases (33.3 %), because it was difficult to localize metastatic lesions with the naked eye, the operation was successfully completed using an imaging system. The completeness of the surgical resection was confirmed by ultrasonography after an average of 5 months postoperatively.
Conclusion
The study found that ICG-MAA-HA dye effectively located metastatic and recurrent thyroid cancer and had favorable results in terms of minimal procedural side effects and potential for assisting the surgeon. A large-scale multi-institutional study is necessary to prove the clinical significance regarding patient survival and disease control.
Similar content being viewed by others
Data Availability
Unavailable because informed consent for sharing patient personal information was not obtained.
References
Nguyen QT, Lee EJ, Huang MG, Park YI, Khullar A, Plodkowski RA. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015;8:30.
Zhao W, You L, Hou X, et al. The effect of prophylactic central neck dissection on locoregional recurrence in papillary thyroid cancer after total thyroidectomy: a systematic review and meta-analysis: pCND for the locoregional recurrence of papillary thyroid cancer. Ann Surg Oncol. 2017;24:2189–98.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
Mitchell A, Gandhi A, Scott-Coombes D, Perros P. Management of thyroid cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130:S150–60.
Viola D, Elisei R. Management of medullary thyroid cancer. Endocrinol Metabol Clin. 2019;48:285–301.
Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg. 2004;130:1214–6.
Ahn D, Sohn JH, Kim H. Surgeon-performed intraoperative tumor localization in recurrent papillary thyroid carcinoma by ultrasound-guided intratumoral indigo carmine injection. World J Surg. 2014;38:1995–2001.
Hartl DM, Chami L, Ghuzlan AA, et al. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence. Ann Surg Oncol. 2009;16:2602–8.
Kim I, Choi HJ, Ryu JM, et al. The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase 2 clinical trial. BMC Surg. 2021;21:1–9.
Bang YJ, Choi HJ, Kim I, et al. The efficacy and safety of an indocyanine green–hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: a multicenter, randomized, open-label, parallel phase 3 clinical trial. Front Oncol. 2023;13:1039670.
Lee E-G, Kim S-K, Han JH, Lee D-E, Jung S-Y, Lee S. Surgical outcomes of localization using indocyanine green fluorescence in breast-conserving surgery: a prospective study. Sci Rep. 2021;11:9997.
Chami L, Hartl D, Leboulleux S, et al. Preoperative localization of neck recurrences from thyroid cancer: charcoal tattooing under ultrasound guidance. Thyroid. 2015;25:341–6.
Soprani F, De Vito A, Bondi F, et al. Preoperative charcoal suspension tattoo for the detection of differentiated thyroid cancer recurrence. Mol Clin Oncol. 2019;10:524–30.
Yi X, Wang F, Qin W, Yang X, Yuan J. Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field. Int J Nanomed. 2014:1347–65
Fanaropoulou NM, Chorti A, Markakis M, Papaioannou M, Michalopoulos A, Papavramidis T. The use of indocyanine green in endocrine surgery of the neck: a systematic review. Medicine. 2019;98:e14765.
Pleijhuis R, Langhout G, Helfrich W, et al. Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg. 2011;37:32–9.
van der Vorst JR, Schaafsma BE, Hutteman M, et al. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013;119:3411–8.
Jung Y-S, Kim S-k, Park I, et al. Surgical targeting of recurrent thyroid cancer using a novel mixture of 99m-technetium macroaggregated albumin and indocyanine green. Surg Innov. 2014;21:622–9.
Iyer NG, Kumar A, Nixon IJ, et al. Incidence and significance of Delphian node metastasis in papillary thyroid cancer. Ann Surg. 2011;253:988–91.
Acknowledgment
This study was supported by National Cancer Center Grants, Republic of Korea (NCC2310622 and NCC2212460-1).
Author information
Authors and Affiliations
Contributions
Study concept and design: SKK, YSJ Data acquisition: CYL, CHR, SYC, SYP, YKL, YH, EKL, YJL, SP, TSK, THK Data analysis and interpretation: JS Article preparation: SKK, JS Article editing: all authors. Final approval: all authors.
Corresponding author
Ethics declarations
Disclosure
Seok-ki Kim is the primary inventor of the domestically patented indocyanine green-macroaggregated-hyaluronic acid mixture. The remaining authors have no conflicts of interest.
Ethical approval
The study protocol was reviewed and approved by the Institutional Review Board of the National Cancer Center, which granted a waiver of informed consent due to the retrospective design of the study (IRB No. NCC2020-0228). The study was registered on cris.nih.go.kr (Identifier: KCT0008577).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file 1 (WMV 61857 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kim, Sk., Seok, J., Lee, C.Y. et al. The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer. Ann Surg Oncol 31, 2349–2356 (2024). https://doi.org/10.1245/s10434-023-14831-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14831-3